Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription


1 Anticancer Res
7 BJU Int
1 BMC Cancer
1 Br J Cancer
1 Cancer Res
3 Eur J Radiol
3 Eur Urol
2 Int J Cancer
1 J Natl Cancer Inst
4 J Urol
1 Oncogene
1 PLoS One
2 Prostate

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Anticancer Res

  1. XIE F, Peng F
    Reduction in Copper Uptake and Inhibition of Prostate Cancer Cell Proliferation by Novel Steroid-based Compounds.
    Anticancer Res. 2021;41:5953-5958.
    PubMed         Abstract available

    BJU Int

  2. TIMM B, Farag M, Liodakis P, Angus D, et al
    Vesico-urethral anastomosis sampling: a forgotten tool for guiding salvage radiation after radical prostatectomy.
    BJU Int. 2021;127 Suppl 1:23-29.
    PubMed         Abstract available

  3. LIGHT A, Burns-Cox N, Maccormick A, John J, et al
    The diagnostic impact of UK regional variations in age-specific prostate-specific antigen guidelines.
    BJU Int. 2021;128:298-300.

  4. Chemotherapeutic treatment of MCRPC and non-MCRPC.
    BJU Int. 2021;128:153-154.

  5. VEERMAN H, Donswijk M, Bekers E, Olde Heuvel J, et al
    Clinical Characteristics of Primary Non-PSMA-Expressing Prostate Cancer on preoperative PSMA PET/CT.
    BJU Int. 2021 Dec 1. doi: 10.1111/bju.15664.
    PubMed         Abstract available

  6. CATHCART P, Ribeiro L, Moore C, Ahmed HU, et al
    Outcomes of the RAFT trial: robotic surgery after focal therapy.
    BJU Int. 2021;128:504-510.
    PubMed         Abstract available

  7. TAMIR S, Hermann D, Margel D, Gavrielli S, et al
    Indications for prostate multiparametric magnetic resonance imaging: changes over 7 years in a single referral centre.
    BJU Int. 2021;128:165-167.

  8. JOHN A, John H, Catterwell R, Selth LA, et al
    Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta-analysis.
    BJU Int. 2021;127 Suppl 1:13-22.
    PubMed         Abstract available

    BMC Cancer

  9. BYEON S, Kim H, Jeon HG, Seo SI, et al
    A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naive prostate cancer.
    BMC Cancer. 2021;21:1281.
    PubMed         Abstract available

    Br J Cancer

  10. SRIVASTAVA SK, Khan MA, Anand S, Zubair H, et al
    MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer.
    Br J Cancer. 2021 Nov 26. pii: 10.1038/s41416-021-01641.
    PubMed         Abstract available

    Cancer Res

  11. XIE W, Reder NP, Koyuncu CF, Leo P, et al
    Prostate cancer risk stratification via non-destructive 3D pathology with deep learning-assisted gland analysis.
    Cancer Res. 2021 Dec 1. pii: 0008-5472.CAN-21-2843.
    PubMed         Abstract available

    Eur J Radiol

  12. SKAWRAN SM, Sanchez V, Ghafoor S, Hotker AM, et al
    Primary staging in patients with intermediate- and high-risk prostate cancer: Multiparametric MRI and (68)Ga-PSMA-PET/MRI - What is the value of quantitative data from multiparametric MRI alone or in conjunction with clinical information?
    Eur J Radiol. 2021;146:110044.
    PubMed         Abstract available

  13. BOSCHHEIDGEN M, Ullrich T, Blondin D, Ziayee F, et al
    Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate.
    Eur J Radiol. 2021;144:109949.
    PubMed         Abstract available

  14. SCHAUDINN A, Michaelis J, Franz T, Ho-Thi P, et al
    High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients.
    Eur J Radiol. 2021;144:109957.
    PubMed         Abstract available

    Eur Urol

  15. WILT TJ, Vo TN, Langsetmo L, Dahm P, et al
    Corrigendum re: "Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)" [Eur Urol 2020;77:713-24].
    Eur Urol. 2021 Nov 23. pii: S0302-2838(21)02157.

  16. NGUYEN AT, Kamrava M
    Re: Jana S. Hopstaken, Joyce G.R. Bomers, Michiel J.P. Sedelaar, Massimo Valerio, Jurgen J. Futterer, Maroeska M. Rovers. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol. In
    Eur Urol. 2021 Nov 27. pii: S0302-2838(21)02159.

  17. LANTZ A, Bock D, Akre O, Angenete E, et al
    Reply to Wei Zhang So, Ziting Wang, and Ho Yee Tiong's Letter to the Editor re: Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Ca
    Eur Urol. 2021 Nov 24. pii: S0302-2838(21)02150.

    Int J Cancer

    Comments on: Antiepileptic drugs and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Int J Cancer. 2021 Dec 2. doi: 10.1002/ijc.33890.

  19. SALMINEN JK, Murtola TJ
    Reply to Comments on: Antiepileptic drugs and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Int J Cancer. 2021 Dec 2. doi: 10.1002/ijc.33887.

    J Natl Cancer Inst

  20. MARK M, von Moos R, Cathomas R, Stoffel S, et al
    RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer.
    J Natl Cancer Inst. 2021 Nov 29. pii: 6446038. doi: 10.1093.

    J Urol

  21. KINNAIRD A, Yerram NK, O'Connor L, Brisbane W, et al
    MRI-guided Biopsy in Active Surveillance of Prostate Cancer.
    J Urol. 2021 Dec 2:101097JU0000000000002343. doi: 10.1097/JU.0000000000002343.
    PubMed         Abstract available

  22. LONERGAN PE, Washington SL 3rd, Cowan JE, Zhao S, et al
    Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
    J Urol. 2021 Dec 2:101097JU0000000000002335. doi: 10.1097/JU.0000000000002335.
    PubMed         Abstract available

  23. KAN WC, Hsieh KL, Chen YC, Ho CH, et al
    Comparison of Surgical or Medical Castration-Related Cardiotoxicity in Patients With Prostate Cancer.
    J Urol. 2021 Dec 2:101097JU0000000000002340. doi: 10.1097/JU.0000000000002340.
    PubMed         Abstract available

  24. WAISMAN MALARET AJ, Chang P, Zhu K, Zheng Y, et al
    Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results From the Canary PASS Cohort.
    J Urol. 2021 Dec 2:101097JU0000000000002354. doi: 10.1097/JU.0000000000002354.
    PubMed         Abstract available


  25. LEE YC, Lin SC, Yu G, Zhu M, et al
    Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
    Oncogene. 2021 Nov 29. pii: 10.1038/s41388-021-02131.
    PubMed         Abstract available

    PLoS One

  26. CHOI W, Lee H
    Identifying disease-gene associations using a convolutional neural network-based model by embedding a biological knowledge graph with entity descriptions.
    PLoS One. 2021;16:e0258626.
    PubMed         Abstract available


  27. NAKAYAMA H, Sekine Y, Oka D, Miyazawa Y, et al
    Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.
    Prostate. 2021 Nov 29. doi: 10.1002/pros.24274.
    PubMed         Abstract available

  28. ZAREI A, Javid H, Sanjarian S, Senemar S, et al
    Metagenomics studies for the diagnosis and treatment of prostate cancer.
    Prostate. 2021 Dec 2. doi: 10.1002/pros.24276.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.